K Number
K180813
Device Name
BTL 799-2
Date Cleared
2018-06-14

(77 days)

Product Code
Regulation Number
890.5850
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
BTL 799-2 is indicated to be used for: - · Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen. - · Strengthening, Toning and Firming of buttocks and thighs.
Device Description
The BTL 799-2 is a non-invasive therapeutic device produces electromagnetic field that interacts with the tissues of the human body. By muscle stimulation, the BTL 799-2 helps to strengthen, tone and firm the abdomen, buttocks and thighs. The device two outputs enable simultaneous treatment by two applicators. The BTL 799-2 is equipped with a large color touch screen with wide view angle that significantly facilitates the use of the device. The on-screen information quides the user stepby-step through the entire therapy procedure. The therapeutic parameters are easily set using the touch screen and buttons on the device. During the therapy the device keeps information about the applied therapy type, remaining therapy time and main therapy parameters on the screen.
More Information

Not Found

No
The summary describes a non-invasive therapeutic device using electromagnetic fields for muscle stimulation. There is no mention of AI, ML, or any related concepts in the intended use, device description, or performance studies. The focus is on the physical mechanism of action and safety standards.

Yes
The device description explicitly states, "The BTL 799-2 is a non-invasive therapeutic device." Additionally, its intended use for muscle strengthening and toning, along with its 'Prescription Use' classification, further supports its therapeutic nature.

No
The device description states it is a "non-invasive therapeutic device" intended for muscle stimulation and strengthening, toning, and firming. Its intended use is for physical improvement, not for diagnosing medical conditions.

No

The device description explicitly states it is a "non-invasive therapeutic device produces electromagnetic field" and mentions "two outputs enable simultaneous treatment by two applicators," indicating it is a hardware device that delivers energy. The software component is described as controlling the hardware and displaying information.

Based on the provided information, the BTL 799-2 is not an IVD (In Vitro Diagnostic) device.

Here's why:

  • Intended Use: The intended use clearly states the device is for "Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen," and "Strengthening, Toning and Firming of buttocks and thighs." These are therapeutic and aesthetic purposes, not diagnostic testing performed on samples taken from the human body.
  • Device Description: The description explains that the device produces an electromagnetic field that interacts with tissues for muscle stimulation. This is a physical interaction with the body, not an analysis of biological samples.
  • Lack of IVD Characteristics: There is no mention of analyzing blood, urine, tissue, or any other biological sample. The device does not perform tests to diagnose diseases or conditions based on these samples.

IVD devices are specifically designed to perform tests on samples taken from the human body to provide information for diagnosis, monitoring, or screening. The BTL 799-2 does not fit this description.

N/A

Intended Use / Indications for Use

BTL 799-2 is indicated to be used for:

  • · Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.
    · Strengthening, Toning and Firming of buttocks and thighs.

Product codes (comma separated list FDA assigned to the subject device)

NGX

Device Description

The BTL 799-2 is a non-invasive therapeutic device produces electromagnetic field that interacts with the tissues of the human body. By muscle stimulation, the BTL 799-2 helps to strengthen, tone and firm the abdomen, buttocks and thighs. The device two outputs enable simultaneous treatment by two applicators.

The BTL 799-2 is equipped with a large color touch screen with wide view angle that significantly facilitates the use of the device. The on-screen information quides the user stepby-step through the entire therapy procedure. The therapeutic parameters are easily set using the touch screen and buttons on the device. During the therapy the device keeps information about the applied therapy type, remaining therapy time and main therapy parameters on the screen.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Abdomen, buttocks and thighs

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Prescription Use

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The BTL 799-2 device has been thoroughly evaluated for electrical safety. The device has been found to comply with the following applicable medical device safety standards:

IEC 60601-1Medical electrical equipment – Part 1: General requirements for basic safety and essential performance
IEC 60601-1-2Medical electrical equipment – Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic disturbances – Requirements and tests
IEC 60601-1-6Medical electrical equipment – Part 1-6: General requirements for basic safety and essential performance – Collateral standard: Usability
IEC 60601-2-10Medical Electrical Equipment – Part 2-10: Particular Requirements for the Basic Safety and Essential Performance of Nerve and Muscle Stimulators
IEC 62366Medical devices - Application of usability engineering to medical devices
IEC 62304Medical device software - Software life cycle processes
ISO 14971Medical devices – Application of risk management to medical devices
ISO 10993-1Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process
ISO 10993-5Biological evaluation of medical devices – Part 5: Tests for in vitro cytotoxicity
ISO 10993-10Biological evaluation of medical devices – Part 10: Tests for irritation and skin sensitization

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K163165

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 890.5850 Powered muscle stimulator.

(a)
Identification. A powered muscle stimulator is an electrically powered device intended for medical purposes that repeatedly contracts muscles by passing electrical currents through electrodes contacting the affected body area.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

June 14, 2018 BTL Industries, Inc. David Chmel VP of Operations 362 Elm Street Marlborough, Massachusetts 01752

Re: K180813

Trade/Device Name: BTL 799-2 Regulation Number: 21 CFR 890.5850 Regulation Name: Powered muscle stimulator Regulatory Class: Class II Product Code: NGX Dated: March 26, 2018 Received: March 29, 2018

Dear David Chmel:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

1

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

William J. Heetderks -S 2018.06.14 16:14:26 -04'00'

  • Carlos L. Peña, PhD, MS for Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
    Enclosure

2

Indications for Use

510(k) Number (if known) K180813

Device Name BTL 799-2

Indications for Use (Describe)

BTL 799-2 is indicated to be used for:

  • · Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.
    · Strengthening, Toning and Firming of buttocks and thighs.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)Over-The-Counter Use (21 CFR 801 Subpart C)
X

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Image /page/3/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three interconnected squares with the letters "BTL" inside each square. To the right of the squares is the text "BTL Industries" in a dark gray sans-serif font. The logo is simple and modern.

510(k) Summary

General Information

| Sponsor: | BTL Industries, Inc.
362 Elm Street
Marlborough, MA 01752
Tel: +1-866-285-1656
Fax: +1-888-499-2502 |
|------------------------------|-----------------------------------------------------------------------------------------------------------------|
| Applicant: | BTL Industries, Inc.
362 Elm Street
Marlborough, MA 01752
Tel: +1-866-285-1656
Fax: +1-888-499-2502 |
| Contact Person: | David Chmel
BTL Industries, Inc.
chmel@btlnet.com |
| Summary Preparation
Date: | June 14, 2018 |

Device Name

Trade/Proprietary Name:BTL 799-2
Primary Classification Name:Stimulator, Muscle, Powered
Classification Regulation:21 CFR 890.5850, Class II
Classification Product Code:NGX

Legally Marketed Predicate Devices

The BTL 799-2 is a state-of-the-art magnetic device with accessories, and is substantially equivalent to the current product that is already cleared for distribution in the USA under the following 510(k) Premarket Notification number:

4

Image /page/4/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three blue squares, each containing the letters "BTL" in white. The squares are arranged in a row, with the first square slightly offset to the left and the third square slightly offset to the right. To the right of the squares is the text "BTL Industries" in gray.

Product Description

The BTL 799-2 is a non-invasive therapeutic device produces electromagnetic field that interacts with the tissues of the human body. By muscle stimulation, the BTL 799-2 helps to strengthen, tone and firm the abdomen, buttocks and thighs. The device two outputs enable simultaneous treatment by two applicators.

The BTL 799-2 is equipped with a large color touch screen with wide view angle that significantly facilitates the use of the device. The on-screen information quides the user stepby-step through the entire therapy procedure. The therapeutic parameters are easily set using the touch screen and buttons on the device. During the therapy the device keeps information about the applied therapy type, remaining therapy time and main therapy parameters on the screen.

Intended Use

BTL 799-2 is indicated to be used for:

  • · Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.
  • · Strengthening, Toning and Firming of buttocks and thighs.

Non-clinical Testing

The BTL 799-2 device has been thoroughly evaluated for electrical safety. The device has been found to comply with the following applicable medical device safety standards:

| IEC 60601-1 | Medical electrical equipment – Part 1: General requirements for basic
safety and essential performance |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IEC 60601-1-2 | Medical electrical equipment – Part 1-2: General requirements for
basic safety and essential performance - Collateral standard:
Electromagnetic disturbances – Requirements and tests |
| IEC 60601-1-6 | Medical electrical equipment – Part 1-6: General requirements for
basic safety and essential performance – Collateral standard: Usability |
| IEC 60601-2-10 | Medical Electrical Equipment – Part 2-10: Particular Requirements for
the Basic Safety and Essential Performance of Nerve and Muscle
Stimulators |
| IEC 62366 | Medical devices - Application of usability engineering to medical
devices |
| IEC 62304 | Medical device software - Software life cycle processes |
| ISO 14971 | Medical devices – Application of risk management to medical devices |

5

Image /page/5/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three blue squares, each nested inside the other, with the letters "BTL" stacked vertically inside the innermost square. To the right of the squares is the text "BTL Industries" in a gray, sans-serif font. The logo is simple and modern, and the use of blue and gray gives it a professional look.

| ISO 10993-1 | Biological evaluation of medical devices – Part 1: Evaluation and
testing within a risk management process |
|--------------|---------------------------------------------------------------------------------------------------------------|
| ISO 10993-5 | Biological evaluation of medical devices – Part 5: Tests for in vitro
cytotoxicity |
| ISO 10993-10 | Biological evaluation of medical devices – Part 10: Tests for irritation
and skin sensitization |

Technological Characteristics

The BTL 799-2 device has the same indications for use and similar technological characteristics and principles of operation as its predicate device. The BTL 799-2 device and its predicate are comprised of a system console and applicator(s). The system console consists of the electromagnetic field generators, computer, and the touch-screen control panel.

Generated electromagnetic field is intended to interact with the tissues of the human body to achieve muscle stimulation. The Essential technical characteristics of the BTL 799-2 and its predicate device, particularly the type of energy, pulse characteristics, type of operation and therapy time, are identical.

Compared to the predicate, the BTL 799-2 device is equipped with larger touch-screen control panel to increase user comfort. Technical characteristics of the applicator are comparable to its predicate. The subject device has two outputs to enable simultaneous treatment by two applicators.

The technological differences between the BTL 799-2 device and the predicate device do not raise any new types of safety or effectiveness questions.

510(k) numberNot AssignedK163165
Device nameBTL 799-2AM-100
Company nameBTL Industries, Inc.BTL Industries, Inc.
Product Code
and RegulationPhysical Medicine
21 CFR 890.5850
NGX – Stimulator, Muscle,
Powered, Muscle ConditioningPhysical Medicine
21 CFR 890.5850
NGX – Stimulator, Muscle, Powered,
Muscle Conditioning

Comparison with the Predicate Device

6

Image /page/6/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three interconnected blue squares with the letters "BTL" inside each square. To the right of the logo is the text "BTL Industries" in a dark gray sans-serif font.

510(k) numberNot AssignedK163165
Device nameBTL 799-2AM-100
Company nameBTL Industries, Inc.BTL Industries, Inc.
Intended UseBTL 799-2 is indicated to be used for:
• Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.
• Strengthening, Toning and Firming of buttocks and thighs.AM 100 is indicated to be used for:
• Improvement of abdominal tone, for strengthening of the abdominal muscles, for development of firmer abdomen.
• Strengthening, Toning and Firming of buttocks and thighs.
Primary FunctionMuscle stimulationMuscle stimulation
Principle of ActionInitiating action potential of nerves results in muscle contractionInitiating action potential of nerves results in muscle contraction
Clinical UsePrescription usePrescription use
Electrical ProtectionClass II, BFClass II, BF
User InterfaceTouch screenTouch screen
Touch screen size15.6" (39.6 cm)8.4" (21.5 cm)
Firmware ControlledYesYes
Type of EnergyMagnetic fieldMagnetic field
Number of outputs21
Number of Magnetic
Coils
in the Applicator11
Magnetic Field
Intensity299-6 applicator: 0.5–1.8 T299-1 applicator: 0.5–1.8 T
299-2 applicator: 0.7–2.5 T
510(k) numberNot AssignedK163165
Device nameBTL 799-2AM-100
Company nameBTL Industries, Inc.BTL Industries, Inc.
Type of OperationContinuousContinuous
Pulse Repetition Rate1 - 150 Hz1 - 150 Hz
Pulse Duration280 ± 20% µs280 ± 20% µs
Pulse Amplitude0 – 100%0 – 100%
Induced Current in
the Tissue28-30 mA28-30 mA
Selection of
parameters (Intensity,
Time)YesYes
Therapy TimeUp to 60 minUp to 60 min
Shape of Stimulation
PulseSymmetrical Biphasic Sine WaveSymmetrical Biphasic Sine Wave
Energy Source100 - 240 V AC, 50-60 Hz100 - 240 V AC, 50-60 Hz
System Dimensions
(W×H×D)500×1380×580 mm500×970×580 mm
(20×55×23 in)(20×38×23 in)
Ambient Temperature-10°C to +55°C-10°C to +55°C
Environmental
SpecificationsFor indoor use onlyFor indoor use only

7

Image /page/7/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three interconnected blue squares, with the letters "BTL" inside the squares. To the right of the squares is the text "BTL Industries" in a dark gray sans-serif font. The logo is simple and modern, and the use of blue and gray gives it a professional look.

Substantial Equivalence

The BTL 799-2 device has the same intended use as its predicate devices. The technological characteristics of the predicate devices are similar to the BTL 799-2 device. Any differences between the predicate devices and BTL 799-2 device have no significant influence on safety or effectiveness of the BTL 799-2 device. Therefore, the BTL 799-2 device is substantially equivalent to the predicate devices.

8

Image /page/8/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three blue squares nested inside each other, with the letters "BTL" in white inside the innermost square. To the right of the square logo is the text "BTL Industries" in a dark gray sans-serif font.

Conclusion

Based upon the intended use and known technical information provided in this pre-market notification, the BTL 799-2 device has been shown to be substantially equivalent to currently marketed predicate device.